Showing results (61-70 of 74) with videos related to

Sort By:
Pageof 8
Nature Reviews. Endocrinology|July 21, 2010
Molecular therapy of breast cancer: progress and future directionsSheng-Xiang Lin, Jiong Chen, Mausumi Mazumdar, et al.
Endocrine Reviews|April 18, 2003
Endocrine and intracrine sources of androgens in women: inhibition of breast cancer and other roles of androgens and their precursor dehydroepiandrosteroneFernand Labrie, Van Luu-The, Claude Labrie, et al.
The Journal of Steroid Biochemistry and Molecular Biology|June 25, 2017
Inhibition of 17beta-hydroxysteroid dehydrogenase type 7 modulates breast cancer protein profile and enhances apoptosis by down-regulating GRP78Xiao-Qiang Wang, Juliette A Aka, Tang Li, et al.
Plos One|October 3, 2013
Crystal structures of human muscle fructose-1,6-bisphosphatase: novel quaternary states, enhanced AMP affinity, and allosteric signal transmission pathwayRong Shi, Ze-Yong Chen, Dao-Wei Zhu, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 13, 2019
Transcriptome of 17β-hydroxysteroid dehydrogenase type 2 plays both hormone-dependent and hormone-independent roles in MCF-7 breast cancer cellsChen-Yan Zhang, Ezequiel-Luis Calvo, Chang-Qing Yang, et al.
The Journal of Steroid Biochemistry and Molecular Biology|November 2, 2015
Impact of structural modifications at positions 13, 16 and 17 of 16β-(m-carbamoylbenzyl)-estradiol on 17β-hydroxysteroid dehydrogenase type 1 inhibition and estrogenic activityRené Maltais, Alexandre Trottier, Xavier Barbeau, et al.
Journal of Molecular Biology|April 22, 2018
Structure of Escherichia coli Arginyl-tRNA Synthetase in Complex with tRNA<sup>Arg</sup>: Pivotal Role of the D-loopPreyesh Stephen, Sheng Ye, Ming Zhou, et al.
The Journal of Biological Chemistry|December 15, 2006
Structure-based inhibitor design for an enzyme that binds different steroids: a potent inhibitor for human type 5 17beta-hydroxysteroid dehydrogenaseWei Qiu, Ming Zhou, Mausumi Mazumdar, et al.
Plos One|July 23, 2013
Dendritic cell immunoreceptor is a new target for anti-AIDS drug development: identification of DCIR/HIV-1 inhibitorsAlexandra A Lambert, Arezki Azzi, Sheng-Xiang Lin, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|September 12, 2002
A concerted, rational design of type 1 17beta-hydroxysteroid dehydrogenase inhibitors: estradiol-adenosine hybrids with high affinityWei Qiu, Robert L Campbell, Anne Gangloff, et al.
Pageof 8